U.S. warns Novartis on Alzheimer's drug promotion (Reuters)
Reuters - A Novartis AG promotion for
Alzheimer's drug Exelon made misleading claims about the
medicine's effectiveness and risks, U.S. health officials
warned the company in a letter released on Tuesday.
Original post by stephend
You must be logged in to post a comment.